Trailing-twelve-month (TTM) revenue is $84.60 Million with a year-over-year growth of (36.71%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $19,552,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $23,795,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2026Period ended 2026-03-31 | $21,146,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $20,104,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $84,597,000 |
Current P/S: $281,892,451 market capitalization ÷ $84,597,000 TTM revenue = 3.33x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:55:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $20.10M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:57:28.529Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Collaboration and Other Revenue | N/A | N/A | N/A | N/A | $5M | N/A |
| Collaboration Revenue | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $75M | $64M | $44M | $46M | $93M | $31M |
| Asia Pacific | $26M | $24M | $21M | $24M |
$84.60M
$84.60 Million
(36.71%)
vs. $133.67M a year ago (TTM)
(10.62%)
5 Year compound annual growth rate
1 Year
(36.71%)
3 Year
(7.08%)
5 Year
(10.62%)
10 Year
(3.15%)
15 Year
+5.46%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $85.33M | ($89.10M) | (51.08%) |
| 2024 | $174.43M | +$68.09M | +64.03% |
| 2023 | $106.34M | +$8.39M | +8.57% |
| 2022 | $97.95M | ($32.63M) | (24.99%) |
| 2021 | $130.58M | ($7.56M) | (5.47%) |
| 2020 |
TTM Growth
(36.71%)
3-Year CAGR
(7.08%)
5-Year CAGR
(10.62%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:57:28.529Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $818,000 |
| N/A |
| N/A |
| N/A |
| Consumables | N/A | $58M | $47M | $42M | $60M | $36M |
|---|
| Grant | N/A | $2M | $0 | N/A | N/A | N/A |
|---|
| Instruments | N/A | $42M | $26M | $37M | $29M | $25M |
|---|
| License | N/A | $147,000 | $964,000 | N/A | N/A | N/A |
|---|
| Product | $100M | $100M | $72M | $79M | $89M | $62M |
|---|
| Product And Service | N/A | N/A | $96M | $105M | $170M | N/A |
|---|
| Product and Service, Other | $7M | $2M | $964,000 | $1M | N/A | N/A |
|---|
| Service | $23M | $26M | $24M | $26M | $81M | N/A |
|---|
| Service and Other Revenue | N/A | N/A | N/A | N/A | N/A | $24M |
|---|
| $19M |
| EMEA | $38M | $43M | $33M | $36M | $52M | $36M |
|---|
| $138.14M |
| +$20.90M |
| +17.83% |
| 2019 | $117.24M | +$4.28M | +3.79% |
| 2018 | $112.96M | +$11.03M | +10.82% |
| 2017 | $101.94M | ($2.51M) | (2.40%) |
| 2016 | $104.45M | ($10.27M) | (8.95%) |
